Skip to main content

Table 3 CLDQ scores (mean ± SD) of chronic hepatitis B patients

From: Significant impairment of health-related quality of life in mainland Chinese patients with chronic hepatitis B: a cross-sectional survey with pair-matched healthy controls

 

Overall (n = 460)

Chronic hepatitis B (n = 323)

Compensated cirrhosis (n = 54)

Decompensated cirrhosis (n = 83)

AB*

5.5 ± 1.1

5.6 ± 1.1

5.4 ± 1.0

5.1 ± 1.2

FA

4.8 ± 1.1

4.8 ± 1.1

4.6 ± 1.1

4.6 ± 1.2

SY*

5.4 ± 0.9

5.5 ± 0.8

5.3 ± 0.8

5.0 ± 0.9

AC*

5.5 ± 1.1

5.7 ± 1.0

5.0 ± 1.2

4.8 ± 1.1

EM

4.8 ± 1.1

4.9 ± 1.1

4.7 ± 0.9

4.9 ± 1.1

WO

5.1 ± 1.2

5.0 ± 1.2

4.9 ± 1.1

5.2 ± 1.0

Overall*

5.2 ± 0.8

5.3 ± 0.8

5.0 ± 0.7

4.9 ± 0.8

  1. AB, abdominal symptoms; FA, fatigue; SY, systemic symptoms; AC, activity; EM, emotional function; WO, worry.
  2. *Significant difference among three patient groups (P < 0.05).
  3. Significantly different compared with chronic hepatitis B group (P < 0.05).